Unfractionated Heparin



Indications and Reactions:

Role Indications Reactions
Primary
Myocardial Infarction 38.7%
Hypertension 12.9%
Gastritis 9.7%
Acute Myocardial Infarction 6.5%
Diabetes Mellitus 6.5%
Pulmonary Embolism 6.5%
Anuria 3.2%
Depression 3.2%
Ischaemia 3.2%
Platelet Aggregation 3.2%
Pneumonia 3.2%
Ulcer 3.2%
Intracardiac Thrombus 40.0%
Muscle Haemorrhage 20.0%
Pancytopenia 20.0%
Red Blood Cell Count Decreased 20.0%
Secondary
Acute Myocardial Infarction 20.4%
Myocardial Infarction 16.3%
Pulmonary Embolism 9.6%
Anticoagulant Therapy 5.8%
Percutaneous Coronary Intervention 5.8%
Cardio-respiratory Arrest 4.4%
Deep Vein Thrombosis 4.4%
Kawasaki's Disease 3.9%
Product Used For Unknown Indication 3.9%
Acute Coronary Syndrome 3.3%
Hypertension 3.3%
Peripheral Artery Thrombosis 3.3%
Atrial Fibrillation 2.8%
Drug Use For Unknown Indication 2.5%
Gastritis 2.5%
Thrombolysis 1.9%
Diabetes Mellitus 1.7%
Intracardiac Thrombus 1.7%
Cerebrovascular Accident Prophylaxis 1.4%
Thrombosis Prophylaxis 1.4%
Pulmonary Embolism 10.9%
Intracardiac Thrombus 9.4%
Coronary Revascularisation 6.3%
Death 6.3%
Haemorrhage 6.3%
Renal Failure Acute 6.3%
Skin Haemorrhage 6.3%
Multi-organ Failure 4.7%
Pancytopenia 4.7%
Red Blood Cell Count Decreased 4.7%
Thrombosis 4.7%
Vascular Operation 4.7%
Cardiac Tamponade 3.1%
Drug Ineffective 3.1%
Hypotension 3.1%
Pain In Extremity 3.1%
Pneumonia 3.1%
Sensory Loss 3.1%
Thrombocytopenia 3.1%
Tinnitus 3.1%
Concomitant
Product Used For Unknown Indication 21.4%
Pulmonary Embolism 7.6%
Rheumatoid Arthritis 7.6%
Anticoagulant Therapy 6.9%
Percutaneous Coronary Intervention 6.9%
Deep Vein Thrombosis 5.3%
Angina Unstable 5.0%
Atrial Fibrillation 5.0%
Drug Use For Unknown Indication 5.0%
Acute Myocardial Infarction 4.2%
Cerebrovascular Accident Prophylaxis 4.2%
Immunosuppression 4.2%
Myocardial Infarction 4.2%
Thrombosis Prophylaxis 3.1%
Antiphospholipid Syndrome 1.9%
Alpha Haemolytic Streptococcal Infection 1.5%
Factor Viii Deficiency 1.5%
Hypertension 1.5%
Tuberculosis 1.5%
Type 2 Diabetes Mellitus 1.5%
Thrombocytopenia 21.1%
Death 15.8%
Off Label Use 8.8%
International Normalised Ratio Increased 7.0%
Myocardial Infarction 7.0%
Catheter Thrombosis 3.5%
Coagulation Time Prolonged 3.5%
Coronary Artery Thrombosis 3.5%
Hepatocellular Injury 3.5%
Occult Blood Positive 3.5%
Paraesthesia 3.5%
Pulmonary Embolism 3.5%
Rheumatoid Arthritis 3.5%
Acute Generalised Exanthematous Pustulosis 1.8%
Acute Myocardial Infarction 1.8%
Cardiac Failure Congestive 1.8%
Catheter Related Complication 1.8%
Cerebral Infarction 1.8%
Cerebrovascular Accident 1.8%
Coronary Artery Disease 1.8%
Interacting
Infection Prophylaxis 27.6%
Dehydration 13.8%
Haemodialysis 13.8%
Oedema 13.8%
Atrial Fibrillation 10.3%
Cerebrovascular Accident Prophylaxis 6.9%
Cerebrovascular Accident 3.4%
Dialysis 3.4%
Ischaemic Heart Disease Prophylaxis 3.4%
Product Used For Unknown Indication 3.4%
Urinary Tract Infection 50.0%
Procedural Haemorrhage 25.0%
Shock Haemorrhagic 25.0%